1-6 of 6
direct trial
Close
Sort by
Journal Articles

Pro-Active Dasatinib Dose Reduction Based on Trough Levels May Minimise Toxicity and Preserve Efficacy - Interim Analysis of the ALLG CML 12 Direct Study

David T Yeung, PhDBSc,FRACP,FRCPA,MBBS, Andrew Grigg, Naranie Shanmuganathan, MBBS FRACP FRCPA, Ann Christine Solterbeck, BSc(Hons) MSc PhDAstat, Deborah L. White, PhD FFSc (RCPA), Susan Branford, PhD FFSc (RCPA), Nicholas Viiala, MBBS FRACP FRCPA, Philip Arthur Rowlings, FRACP,FRCPA,MBBS,MS, Anthony K Mills, FRACP, FRCPA, MBBS, Jake Shortt, MBBS FRACP FRCPA PhD, Campbell Tiley, MBBS, FRACP, David M Ross, MD PhD, David Kipp, MBBS,FRCPA,FRACP, Rosemary Anne Harrup, MBBS, FRACP, FRCPA, Ilona Cunningham, MBBS FRACP FRCPA, John Kwan, MBBS,FRACP,FRCPA, Richard Eek, MBChB MMED, FCP, FRACP., Howard Mutsando, MBChB FRACP FRCPA, Ken-Soon Tan, MMed FRACP MRCP(UK) MA MBBChir BA(Hons), Kate Burbury, MBBS, FRACP, FRCPA, DPhil, Matthew P.F. Wright, MBBS, FRCPA, FRACP, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, On Behalf of the ALLG
Journal: Blood
Blood (2019) 134 (Supplement_1): 4150.
https://doi.org/10.1182/blood-2019-127619
Published: 2019
Journal Articles

Simulated Treatment Comparison (STC) of Human Mesenchymal Stromal Cells (Remestemcel-L, REM) and Ruxolitinib (RUX) for Steroid-Refractory Acute Graft-Versus-Host Disease (SR aGVHD) Pediatric Patients

Tracy Westley, MPH, Dimitrios Tomaras, MSc, Eric Strati, PharmD, Donna Skerrett, MD MS, Anna Forsythe, PharmD, MBA, MMSc, Gabriel Tremblay, DBA, MSc, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4545.
https://doi.org/10.1182/blood-2019-131098
Published: 2019
Journal Articles

Estimating Utilities for Panobinostat in Combination with Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma; Evidence from the Panorama-1 Trial

Istvan Majer, Arun Krishna, Gijs van de Wetering, Jesús F. San-Miguel, MD PhD, Paul G. Richardson
Journal: Blood
Blood (2015) 126 (23): 4504.
https://doi.org/10.1182/blood.V126.23.4504.4504
Published: 2015
Journal Articles

Defined, Serum-Free Conditions for in Vitro culture of Primary Human T-ALL Blasts

Olena O Shevchuk, Arla J Yost, Renea Gooch, Samuel D Gusscott, James M You, MD, PhD, Tan A Ince, MD, PhD, Jon C Aster, MD, PhD, Andrew P Weng, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3537.
https://doi.org/10.1182/blood.V120.21.3537.3537
Published: 2012
Journal Articles

D-DImer Dosing for Risk Prediction of Central Venous Catheter Thrombosis (The DIReCT Trial).

Stephane Doucet, MD, Marie-Jose Miron, MD, Soulieres Denis, MD, Belanger Karl, MD, Florescu Marie, MD, Ayoub Jean-Pierre, MD, Yelle Louise, MD, Harold J. Olney, MD, Normand Blais, MD
Journal: Blood
Blood (2007) 110 (11): 3980.
https://doi.org/10.1182/blood.V110.11.3980.3980
Published: 2007
Journal Articles

Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.

James Douketis, MD, Deborah Cook, MD, Nicole Zytaruks, MSc, Diane Heels-Ansdell, MSc, Mark Crowther
Journal: Blood
Blood (2007) 110 (11): 304.
https://doi.org/10.1182/blood.V110.11.304.304
Published: 2007